Nicardipine Hydrochloride | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Nicardipine Hydrochloride
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Nicardipine Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

32 API Suppliers, 15 USDMF, 1 JDMF, 2 EU WC, 2 KDMF, 7 NDC API, 20 Listed Suppliers, $ API Reference Price

32 API Suppliers
15 USDMF
1 JDMF
2 EU WC
2 KDMF
7 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

60 FDF Dossiers, 45 FDA Orange Book, 6 Europe, 9 Listed Dossiers

60 FDF Dossiers
45 FDA Orange Book
6 Europe
9 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML), INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

INJECTABLE;INTRAVENOUS - 20MG/200ML (0.1MG/ML)
INJECTABLE;INJECTION - 25MG/10ML (2.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
INJECTABLE;INTRAVENOUS - 40MG/200ML (0.2MG/ML)

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 6 SPI Pharma, 8 DKSH, 3 Faran Shimi Pharmaceutical, 4 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 2 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 11 BASF, 3 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 6 Kerry, 3 Lonza Capsugel, 7 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 28 Roquette, 2 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

40 Fillers, Diluents & Binders, 28 Coating Systems & Additives, 16 Direct Compression, 16 Thickeners and Stabilizers, 14 Taste Masking, 14 Controlled & Modified Release, 13 Film Formers & Plasticizers, 12 Lubricants & Glidants, 11 Granulation, 10 Co-Processed Excipients, 8 Empty Capsules, 7 Disintegrants & Superdisintegrants, 7 Chewable & Orodispersible Aids, 7 Parenteral, 5 Solubilizers, 4 Topical, 4 Emulsifying Agents, 3 Coloring Agents, 1 Soft Gelatin, 1 API Stability Enhancers, 1 Surfactant & Foaming Agents, 1 Rheology Modifiers

40 Fillers, Diluents & Binders
28 Coating Systems & Additives
16 Direct Compression
16 Thickeners and Stabilizers
14 Taste Masking
14 Controlled & Modified Release
13 Film Formers & Plasticizers
12 Lubricants & Glidants
11 Granulation
10 Co-Processed Excipients
8 Empty Capsules
7 Disintegrants & Superdisintegrants
7 Chewable & Orodispersible Aids
7 Parenteral
5 Solubilizers
4 Topical
4 Emulsifying Agents
3 Coloring Agents
1 Soft Gelatin
1 API Stability Enhancers
1 Surfactant & Foaming Agents
1 Rheology Modifiers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

2 DATA COMPILATION #PharmaFlow
18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

7 Finished Drug Prices

7 Finished Drug Prices

MARKET PLACE

17 APIs, 2 FDF Dossiers

17 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

22 US Patents, 4 US Exclusivities, 5 Health Canada Patents

22 US Patents
4 US Exclusivities
5 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 4 Others

1 EDQM
1 USP
4 Others

$ API Ref.Price (USD/KG) : 10,358 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

5 All

01 5Blank

filter Patent Reset all filters

5 All

01 21200494

02 31240930

filter Product Reset all filters

5 All

01 5Blank

filter Dosage Reset all filters

5 All

01 5Blank

filter Exp Date Reset all filters

5 All

01 22003-02-11

02 32005-08-23

Product Main Page

01

Nicardipine Hydrochloride

BioAsia

Not Confirmed

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2003-02-11

Date Granted :

Nicardipine Hydrochloride

Brand Name :

Patent Number : 1200494

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2003-02-11

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Nicardipine Hydrochloride

BioAsia

Not Confirmed

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2003-02-11

Date Granted :

Nicardipine Hydrochloride

Brand Name :

Patent Number : 1200494

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2003-02-11

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

Nicardipine Hydrochloride

BioAsia

Not Confirmed

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2005-08-23

Date Granted :

Nicardipine Hydrochloride

Brand Name :

Patent Number : 1240930

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2005-08-23

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

Nicardipine Hydrochloride

BioAsia

Not Confirmed

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2005-08-23

Date Granted :

Nicardipine Hydrochloride

Brand Name :

Patent Number : 1240930

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2005-08-23

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

Nicardipine Hydrochloride

BioAsia

Not Confirmed

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2005-08-23

Date Granted :

Nicardipine Hydrochloride

Brand Name :

Patent Number : 1240930

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2005-08-23

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!